Bloomberg Anywhere Remote Login Bloomberg Terminal Demo Request


Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.


Financial Products

Enterprise Products


Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000


Industry Products

Media Services

Follow Us

Merrion Pharma Says Novo Nordisk Won’t Be Exercising Option

Oct. 20 (Bloomberg) -- Merrion Pharmaceuticals Plc said it has been informed by its partner, Novo Nordisk A/S, that Novo will not be exercising an option described in the agreement announced by Merrion on Dec. 22. “Merrion will not meet its revenue targets for 2011,” it said.    Link to Statement:{NSN LTDEEY3HBS3K <GO>}

Link to Company News:{MERR ID <Equity> CN <GO>} Link to Company News:{NOVOB DC <Equity> CN <GO>}

To contact the editor responsible for this story: Dara Doyle at

Please upgrade your Browser

Your browser is out-of-date. Please download one of these excellent browsers:

Chrome, Firefox, Safari, Opera or Internet Explorer.